Industry landscapes
The companies, capital and talent shaping life sciences in Sweden. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
Recently founded means a recorded 2023–2026 founding year and no recorded parent, acquirer or public-company status. These companies are not labelled startups without that separate classification.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
37 of 809 tracked companies have open roles.
256 of 809 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 403 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 21.3% of disclosed capital, while 68.4% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $153.45M | 36 | 38 |
| 2017 | $138.62M | 30 | 30 |
| 2018 | $231.66M | 36 | 40 |
| 2019 | $120.65M | 31 | 52 |
| 2020 | $349.96M | 41 | 42 |
| 2021 | $179.66M | 15 | 32 |
| 2022 | $250.18M | 18 | 30 |
| 2023 | $143.85M | 11 | 31 |
| 2024 | $105.76M | 5 | 19 |
| 2025 | $215.7M | 2 | 26 |
Share of all disclosed company funding.
477 recorded rounds since 2016
Recorded participation in life sciences company rounds since 2016.
Backed by Rubicon Healthcare Partners and Arch Venture Partners and others.
Backed by European Investment Bank.
Backed by Athyrium Capital Management.
Backed by Navigare Ventures.
Backed by Pablo Legorreta.
Backed by Danske Bank and Mellby Gård and others.
Backed by Mellby Gård and AMF.
Backed by Scandinavian Life Science Venture.
Backed by TVM Capital and TPG.
Backed by Abingworth and HealthCap and others.
Backed by Healthcap and Industrifonden and others.
Backed by AMF and Mellby Gård and others.
Backed by Life Sciences Partners and Ysios Capital and others.
Backed by Novo Holdings and Johnson & Johnson Innovation and others.
No reviewed exact national-ID connector has yet been qualified for Sweden; this is a checked implementation boundary, not evidence that filings are absent.; No reviewed exact national-ID connector has yet been qualified for Sweden; this is a checked implementation boundary, not evidence that filings are absent.
How the Sweden companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
23 of these companies (2.8%) publish at least one Android app — 30 apps in all, carrying 1.1M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| Detecht - Motorcycle App & GPSDeTecht | 675.5K | 4 | Maps & Navigation |
| CellaVision CellAtlasCellavision | 243.2K | 4.4 | Medical |
| Flow - Depression treatmentFlow Neuroscience | 96K | 3.5 | Health & Fitness |
| IQoroIQoro | 16.4K | — | Health & Fitness |
| Zinzino GoCoreZinzino | 14.4K | — | Lifestyle |
| Tobii Dynavox BeamTobii Dynavox | 10.9K | 3.3 | Communication |
| Coala Appcoala life | 9.1K | 4.1 | Medical |
| Navina SmartWellspect HealthCare | 2.9K | — | Medical |
| EXOPULSE AppEXOPULSE | 1.5K | — | Medical |
| Osstell SmartPegsOsstell | 1.2K | — | Medical |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q2–2026Q1).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Wearable Technology | 7 | 781.5K | Detecht - Motorcycle App & GPS 675.5K | |
| Assistive Tech | 8 | 689.3K | Tobii Dynavox Beam 10.9K | |
| Medical Devices | 4 | 684.8K | Coala App 9.1K | |
| Neurology | 6 | 123.8K | Flow - Depression treatment 96K | |
| Disease Self Management | 5 | 96.8K | EEG Recorder - Flow 423 | |
| Nutraceuticals Tech | 3 | 15.3K | Zinzino GoCore 14.4K | |
| Healthcare Booking Platforms | 2 | 14.7K | Dermicus 260 | |
| Healthcare It | 5 | 12K | QTA Access Point E 375 |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 22 of 30 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
24 companies hiring · $2.21B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
NEW YORK – Swedish startup Moleculent said on Thursday that it has raised $20 million in extended Series A financing to help drive the commercialization of its spatial functional proteomics platform for profiling cell-cell communication.
Swedish company Melt&Marble, which raised $8.5 million in December 2025
BioLamina, a Stockholm-based biotech scale-up focused on matrix biology and cell culture has secured a €20 million financing commitment from the European Investment Bank (EIB) to support the development of cell therapies for chronic diseases.
In light of the Company's collaboration with BDO LLP's UK Life Sciences M&A team regarding business development efforts in strategically important markets, it was resolved unanimously that the merger plans regarding the absorption of the wholly owned subsidiaries Klaria Incentive AB, Karessa Incentive AB and Karessa Pharma AB, established on May 24, 2025, shall be applicable in Klaria Pharma Holding AB (publ).
Claret Capital Partners (‘Claret’), Europe’s largest independent growth debt fund manager has made an investment, through its Fund IV, of up to EUR 28 million in Cinclus Pharma Holding AB (publ) (‘Cinclus Pharma’), a late‑stage clinical pharmaceutical company developing next‑generation treatments for gastric acid‑related diseases.
NEOGAP Therapeutics AB , a biotech based in Sweden and led by CEO Samuel Svensson raised SEK 87 M ($9.5 M) financing.
The all-share transaction combines the two companies, with It Works! receiving $30 million in Zinzino B-shares.
Smart Eye Aktiebolag (publ) ('Smart Eye') has entered into an agreement to acquire all shares in the Swedish AI-based software company Sightic Analytics AB from its current shareholders for a fixed purchase price of SEK 60.5 million.
Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon').
Lund-based MedVasc has raised €2.2 million through subscriptions exclusively from existing shareholders
Top 10 categories among 357 recorded events in the 24-month window.
10 companies with recorded IPO activity
Follow-on Offering1 reports
IPO1 reports
IPO1 reports
IPO · Nasdaq First North1 reports
IPO · First North Premier1 reports
IPO1 reports
IPO · Nasdaq Stockholm2 reports
IPO · Nasdaq Stockholm1 reports
24 tracked people moves
Appointment Chief Executive Officer and President
Appointment Member of the Board of Directors
Appointment Chief Financial Officer
Appointment Chief Executive Officer
Departure Previously Chief Financial Officer
Appointment Chief Financial Officer
Departure Previously Chief Financial Officer
Appointment Chief Financial Officer
3 recorded customer wins
Customer: Biopharmaceutical
Customer: genetic tradingHealthcare
Customer: genentechBiopharmaceutical
3 companies with reported reductions
6 rolescost savings
98 rolesstrategic focus shift
70.0% rolescost reduction
10 recorded events
ongoing investigationSwedish Economic Crime Authority
trading haltFirst North Growth Market
bankrupt declaredGothenburg District Court
shares removed from tradingNasdaq Stockholm AB
2 tracked suits
suspected fraudulent financial transactionsCriminal · Filed
warranty claims related to acquisitionCivil ·
Reported company results in the recorded window.
Median across 79 reported growth observations; companies may contribute multiple periods.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| Klaria→Klaria ↗ | Announced | 2026-03-19 | Not stated in snapshot |
| Klaria→Karessa | Announced | 2026-03-19 | Not stated in snapshot |
| Zinzino→It Works! Marketing International UC | Announced | 2026-02-11 | $30.0M |
| Smart Eye Aktiebolag→sightic ↗ | Announced | 2026-02-04 | Not stated in snapshot |
| Nanologica→syntagon | Announced | 2026-02-02 | Not stated in snapshot |
| CLS→ground control | 2026-01-27 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
0 postings in the preceding 12 months. The full 1-posting snapshot covers 1 employers.
0 tracked postings mention remote work.
| Company | Employees |
|---|---|
| BioGaia ↗ | 215 |
| Zinzino ↗ | 213 |
| Hansa Biopharma ↗ | 162 |
| Q-linea ↗ | 149 |
| Oncopeptides ↗ | 114 |
| Affibody ↗ | 113 |
| mips ab ↗ | 108 |
| BioInvent ↗ | 103 |
570 founders and chief executives across 386 companies.
Hansa Medical, ex-Santhera Pharmaceuticals, ex-Life Science Industry, INSEAD, 2017
Ex-Essity, BSN medical, EQT Partners, Beiersdorf. Karlstad University BSc 1993
Itb Med, ex-Itbmed, ex-Karolinska Institutet Science Park, Stockholms universitet/Stockholm University, 1988
Immunovia, ex-Myriad Genetics, ex-Astute Solutions, Northwestern University - Kellogg School of Management, 1999
Positive Capital Partners, RAL Capital, ex-CEO Pharmalink, Omega Fund Management. Stockholm School of Economics BA 1985, INSEAD MBA 1992
Ex-PerkinElmer, Vanadis Diagnostics, Agilent Technologies. University of Sydney MSc 2001, Uppsala University PhD 2008
Co-Founder Sequent Invest, BioLamina, Funera, Deloitte.Lund University MSc 2004
HealthCap, ex-Bayer, Merck Serono. University of Oslo MS 2013
Faculty of Sciences of the University of Porto BS, University of Porto, Imperial College London PhD
Anacardio, ex-Sobi Swedish Orphan Biovitrum, ex-Biovitrum, Stockholm University, 2015
ex-HPR project, Ericsson. KTH PHD 2012
Elypta, ex-Praktikertjanst, ex-Arthur D Little, University of Cambridge, 2013
61 profiles with education records.
2 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
192,151 articles in the measured 12-month window.
Life Sciences coverage across Sweden · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 26,379 |
| 2021Q3 | 26,337 |
| 2021Q4 | 25,862 |
| 2022Q1 | 29,978 |
| 2022Q2 | 33,446 |
| 2022Q3 | 29,859 |
| 2022Q4 | 36,947 |
| 2023Q1 | 38,853 |
| 2023Q2 | 37,339 |
| 2023Q3 | 38,862 |
| 2023Q4 | 33,700 |
| 2024Q1 | 41,933 |
| 2024Q2 | 48,272 |
| 2024Q3 | 45,447 |
| 2024Q4 | 46,977 |
| 2025Q1 | 64,141 |
| 2025Q2 | 38,687 |
| 2025Q3 | 113,541 |
| 2025Q4 | 20,925 |
| 2026Q1 | 27,816 |
Article volume measures coverage, not market sales.
481 recorded company events across 93 companies; percentages use that event total.
Life Sciences coverage across Sweden · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
Life Sciences coverage across Sweden
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| countries | 4,193 | 1,858 | 126% |
| tariff negotiations | 901 | 123 | 633% |
| trade dispute mechanisms | 488 | 52 | 838% |
| bilateral trade | 458 | 47 | 874% |
| free trade deals | 458 | 59 | 676% |
| final match recaps | 362 | 141 | 157% |
| women\'s champions league | 358 | 198 | 81% |
| ski competitions | 317 | 198 | 60% |
| thrash rock elements | 310 | 27 | 1048% |
| ice sports | 308 | 93 | 231% |
| summer olympics athletics | 35 | 275 | -87% |
| olympic career milestones | 67 | 271 | -75% |
| budget motel | 6 | 268 | -98% |
| olympians career highlights | 67 | 268 | -75% |
| motel | 0 | 262 | -100% |
Life Sciences coverage across Sweden
territories, disputed islands, countries
8.2% critical · 6.8% positiveice palace hotel, ice hotel, budget motel
35.5% critical · 42.3% positivequarterly results, dc fast-charging deployment, earnings report
30.0% critical · 48.4% positiveLife Sciences coverage across Sweden. Topic labels describe recorded classifications and can include broad context.
53,147 papers in the recorded worldwide scope.
Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.
Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob
Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases
Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Common problems researchers identify · 0117.3% of this theme group
Researchers discuss challenges in using microbes and plants for renewable fuels and biorefinery processes.
Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)
A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application
Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability
| Year | Share index |
|---|---|
| 2022 | 60.6 |
| 2023 | 59.3 |
| 2024 | 61.9 |
| 2025 | 67.0 |
Common problems researchers identify · 0216.8% of this theme group
Papers highlight microbial hazards and nutritional impacts linked to food manufacturing and consumer health.
Food safety (130) · Food processing (74) · Food products (50) · Human health (90)
Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures
Nutritional quality and processing of plant proteins for healthy and sustainable foods
| Year | Share index |
|---|---|
| 2022 | 70.2 |
| 2023 | 72.4 |
| 2024 | 77.4 |
| 2025 | 99.2 |
Common problems researchers identify · 0315.8% of this theme group
Studies examine hurdles in controlling gene activity, mRNA delivery, and cell‑culture models for medicine.
Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)
Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research
Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with
| Year | Share index |
|---|---|
| 2022 | 2510.1 |
| 2023 | 2495.8 |
| 2024 | 2199.0 |
| 2025 | 1697.8 |
Common problems researchers identify · 0415.4% of this theme group
Research points to difficulties in improving plant nutrient uptake and breeding for resilient, high‑yield crops.
Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)
Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants
Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies
| Year | Share index |
|---|---|
| 2022 | 1635.2 |
| 2023 | 1667.4 |
| 2024 | 1799.9 |
| 2025 | 2026.9 |
Common problems researchers identify · 0515.3% of this theme group
Works address obstacles in pest control, host resistance, and integrated management of plant pathogens.
Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)
Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens
Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions
| Year | Share index |
|---|---|
| 2022 | 27.8 |
| 2023 | 29.2 |
| 2024 | 27.8 |
| 2025 | 37.2 |
Common problems researchers identify · 069.9% of this theme group
Authors flag the spread of drug‑resistant bacteria in humans, livestock, and the environment.
Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)
Antimicrobial resistance in humans, livestock and the wider environment
Antimicrobial use and resistance
| Year | Share index |
|---|---|
| 2022 | 886.3 |
| 2023 | 838.0 |
| 2024 | 911.9 |
| 2025 | 963.5 |
Common problems researchers identify · 079.4% of this theme group
Papers cover diverse, unrelated subjects ranging from academic writing styles to legal conferences.
Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)
Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar
Obiteljska grupna konferencija: prilika za građansko pravosuđe?
| Year | Share index |
|---|---|
| 2022 | 18.4 |
| 2023 | 21.9 |
| 2024 | 17.8 |
| 2025 | 12.5 |
Cautions · 0121.5% of this theme group
Researchers urge caution interpreting in‑vitro toxicity results due to stress responses and assay limitations.
In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)
Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells
Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes
| Year | Share index |
|---|---|
| 2022 | 1034.9 |
| 2023 | 1110.3 |
| 2024 | 911.7 |
| 2025 | 818.5 |
Cautions · 0214.6% of this theme group
Studies caution about translating genomic predictions into practical breeding outcomes and trait stability.
Agriculture (45) · Selection (26) · Production (28) · Trait (16)
Genomic selection in plant breeding: from theory to practice
Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro
| Year | Share index |
|---|---|
| 2022 | 1437.3 |
| 2023 | 1478.4 |
| 2024 | 1637.4 |
| 2025 | 1817.4 |
Cautions · 0313.9% of this theme group
Works highlight uncertainties in efficacy, safety, and environmental impact of novel feed supplements.
Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)
Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production
The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes
| Year | Share index |
|---|---|
| 2022 | 22.2 |
| 2023 | 20.9 |
| 2024 | 17.3 |
| 2025 | 18.2 |
Cautions · 0413.6% of this theme group
Papers stress the need for rigorous safety evaluation of emerging food additives and contaminants.
Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives
| Year | Share index |
|---|---|
| 2022 | 91.3 |
| 2023 | 89.1 |
| 2024 | 95.4 |
| 2025 | 105.8 |
Cautions · 0513.5% of this theme group
Authors point out complexities in measuring genomic instability and interpreting repair pathway data.
Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
| Year | Share index |
|---|---|
| 2022 | 2415.6 |
| 2023 | 2417.4 |
| 2024 | 2125.5 |
| 2025 | 1613.8 |
Cautions · 0611.7% of this theme group
Research warns that antibiotic practices can promote resistance alongside biocides and heavy metals.
Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses
Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens
| Year | Share index |
|---|---|
| 2022 | 886.3 |
| 2023 | 838.0 |
| 2024 | 911.9 |
| 2025 | 963.5 |
Cautions · 0711.3% of this theme group
Studies caution about low‑dose strategies and the ecological consequences of altering pesticide applications.
Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)
The use of fungal entomopathogens as endophytes in biological control: a review
Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m
| Year | Share index |
|---|---|
| 2022 | 66.9 |
| 2023 | 65.3 |
| 2024 | 66.9 |
| 2025 | 75.8 |
Opportunities · 0117.4% of this theme group
Opportunities arise from novel antibody formats and fluorescence methods for in‑vivo cell analysis.
Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)
Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom
Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>
| Year | Share index |
|---|---|
| 2022 | 561.4 |
| 2023 | 615.1 |
| 2024 | 467.1 |
| 2025 | 455.3 |
Opportunities · 0217.2% of this theme group
Research explores manipulating gene expression and apoptosis pathways to treat cancers and metabolic disorders.
Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)
Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc
RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice
| Year | Share index |
|---|---|
| 2022 | 364.0 |
| 2023 | 394.7 |
| 2024 | 257.4 |
| 2025 | 261.8 |
Opportunities · 0314.6% of this theme group
Papers highlight the potential of bioactive ingredients to improve health and support sustainable diets.
Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)
Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives
PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY
| Year | Share index |
|---|---|
| 2022 | 26.7 |
| 2023 | 26.2 |
| 2024 | 27.1 |
| 2025 | 45.2 |
Opportunities · 0413.7% of this theme group
Studies identify DNA methylation and RNA signatures as promising tools for diagnosing and monitoring diseases.
Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)
Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders
Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA
| Year | Share index |
|---|---|
| 2022 | 2397.7 |
| 2023 | 2377.6 |
| 2024 | 2114.7 |
| 2025 | 1613.7 |
Opportunities · 0513.5% of this theme group
Research points to plant‑derived compounds and microbial metabolites as new strategies against resistant pathogens.
Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)
Plants as sources of new antimicrobials and resistance-modifying agents
Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance
| Year | Share index |
|---|---|
| 2022 | 524.8 |
| 2023 | 510.4 |
| 2024 | 554.5 |
| 2025 | 649.8 |
Opportunities · 0611.9% of this theme group
Works reveal advances in QTL mapping and selection to boost yield and stress tolerance in cereals.
Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)
Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield
GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES
| Year | Share index |
|---|---|
| 2022 | 53.0 |
| 2023 | 45.3 |
| 2024 | 39.2 |
| 2025 | 40.8 |
Opportunities · 0711.6% of this theme group
Papers discuss microbial fermentation and by‑product valorization to enhance agricultural sustainability.
Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)
Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health
Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress
| Year | Share index |
|---|---|
| 2022 | 1514.8 |
| 2023 | 1566.1 |
| 2024 | 1742.6 |
| 2025 | 1980.2 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Descriptive | 40.2% | 17.1% |
| Promising | 30.4% | 37.7% |
| Breakthrough | 14.1% | 26.3% |
| Problem-identifying | 8.3% | 9.7% |
| Cautionary | 3.5% | 4.5% |
| Comparative | 2.4% | 3.8% |
| Critical | 1.0% | 0.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities | 87 | 0.21% | 25 (28.7%) | 0.21% |
| Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste | 61 | 0.15% | 4 (6.6%) | 0.15% |
| Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict | 12 | 0.03% | 2 (16.7%) | 0.03% |
| Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya | 3 | 0.01% | 3 (100.0%) | 0.01% |
| Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat | 1 | 0.0% | 0 (0.0%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
| Carbon & emissions of compute | 0 | 0.0% | 0 (%) | 0.0% |
| Labour & data work | 0 | 0.0% | 0 (%) | 0.0% |
| Concentration of compute power | 0 | 0.0% | 0 (%) | 0.0% |
Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.
Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.
Published patent filings in the recorded source window.
Company counts, hiring and disclosed funding across the recorded hubs.
29.3% across the displayed hubs
7 companies hiring · $684.0M disclosed funding
Explore companies in Stockholm ↗
21.6% across the displayed hubs
4 companies hiring · $662.4M disclosed funding
Explore companies in Lund ↗
14.4% across the displayed hubs
8 companies hiring · $274.5M disclosed funding
Explore companies in Gothenburg ↗
13.7% across the displayed hubs
5 companies hiring · $231.7M disclosed funding
Explore companies in Uppsala ↗
7.3% across the displayed hubs
3 companies hiring · $219.2M disclosed funding
Explore companies in Solna ↗
6.4% across the displayed hubs
2 companies hiring · $74.7M disclosed funding
Explore companies in Malmo ↗
4.5% across the displayed hubs
1 companies hiring · $94.1M disclosed funding
Explore companies in Umea ↗
2.8% across the displayed hubs
0 companies hiring · $4.7M disclosed funding
Explore companies in Helsingborg ↗Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 1 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗